Eli Lilly (LLY) rated Sell/Avoid: overvaluation, slowing GLP-1 growth, Novo competition, bearish technicals and insider selling. Click here to read more.

February fiscal flows added a $360B+ private sector surplus, boosting liquidity and risk assets; Fed near peak rates.

Gold is extending the recovery above the $5,200 barrier in Asian trades on Wednesday, as buyers appear hopeful heading into ...

Uncover the best isometric RPGs that gaming has to offer, ranked by their impeccable gameplay, unmatched storytelling, and ...